# An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler DPI

> **NCT02018549** · PHASE2 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 72 (actual)

## Conditions studied

- COPD

## Interventions

- **DEVICE:** Inhalation through Chiesi NEXThaler DPI

## Key facts

- **NCT ID:** NCT02018549
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02018549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02018549, "An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler DPI". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02018549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*